Previous studies have unveiled the critical role of exosome,6 AKT pathway7 and immunology alterations8 in the progression of melanoma, yet effective approaches for melanoma, especially for late‐staged patients, are still lacking. The gene discussed is AKT1; the disease is melanoma.